MedTech News
.................... by Andrew Celentano
Iron supplements restore muscle strength in mouse model of muscular dystrophy
Researchers at Kumamoto University have demonstrated that iron supplementation can significantly alleviate muscle pathology and functional decline in a mouse model of facioscapulohumeral muscular dystrophy (FSHD), a rare genetic muscle disease for which no effective treatment currently exists.
Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical Wearables as a Catalyst for Accelerated Commercial Launch
BELLEVUE, Wash., Jan. 22, 2026 /PRNewswire/ — Woori IO, an OSR company developing next-generation noninvasive glucose monitoring technologies, today commented on the U.S. Food and Drug Administration’s recent clarification regarding non-medical-grade wearable devices, noting that the FDA’s position establishes a regulatory framework highly conducive to Woori IO’s commercialization strategy.
Your Breath May Reveal Hidden Changes in the Gut Microbiome
Learn how chemicals released by gut microbes end up in exhaled breath, and how researchers used those signals to identify microbial communities linked to disease.
Zimmer Biomet launches new foot and ankle system
Zimmer Biomet (NYSE: ZBH)+
recently announced the Brachiator mini-rail external fixation system.
Bridge to Life wins FDA De Novo for transplant liver perfusion system
Bridge to Life has received FDA De Novo clearance for its VitaSmart hypothermic oxygenated perfusion (HOPE) system for liver transplantation.
SonoMotion achieves FDA clearance for kidney-stone-treating lithotripsy
SonoMotion has received FDA 510(k) clearance for its Break Wave lithotripsy device to treat kidney stones.
Intuitive wins FDA clearances for cardiac procedures on da Vinci 5
Intuitive Surgical (Nasdaq: ISRG)+
has received FDA clearance for “several cardiac procedures,” CEO Dave Rosa said today while announcing the surgical robotics company’s latest financial and operating results.
Automated 3D heart tissue platform speeds up cardiac drug testing
Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to develop a new platform that enables the automated production of 3D cardiac microtissues.